Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Obamacare’s double-digit rate hike, explained in 400 words

piggy bank
piggy bank

Obamacare premiums are on track to rise faster than ever before in 2017.

The Obama administration released data Monday showing that premiums for midlevel plans will rise, on average, 22 percent between 2016 and 2017.

Yes, that is a huge increase. Last year premiums went up by 7.5 percent.

Premiums are rising on the Obamacare marketplaces largely because the people who signed up for coverage were sicker than the insurance companies expected. This led some health insurers (like Aetna and UnitedHealth) to leave the marketplace. The insurance companies that stayed behind realized they’d have to charge higher premiums in order to cover their members’ medical bills.

What does this mean for Obamacare customers? Most Obamacare enrollees (83 percent) receive subsidies that limit the amount they have to spend on premiums. They only have to spend a certain percent of their income, and then the government will cover the rest.

These people will likely be somewhat insulated from the premium increases. But the premium hike could still be disruptive. These people might have to switch to a new plan if another insurer is offering a lower premium than the one they currently use.

But another 17 percent of Obamacare enrollees don’t receive premium subsidies. And these people are going to be in a really tough spot. They’ll need to decide whether they want to continue spending more to buy their same coverage — or if the insurance doesn’t provide enough value at the higher price.

What does this mean for the future of the law more generally? That’s really hard to tell right now — but there seems to be two plausible interpretations of the data.

One is that this is a one-time course correction. When Obamacare launched, premiums were much lower than analysts had expected. Insurance plans are now bringing their premiums more in line with expectations, and after they do that, they won’t have to make these big rate increases again.

The other is that this is the start of a series of higher rate increases for the health care law — that these new, high premiums might encourage some healthy people (especially those without subsidies) to leave the individual market. Subsides act as a powerful counter-balance to this second scenario, though, by capping enrollees’ contributions.

In either case, these numbers are bad news for Obamacare — we just don’t know how bad, exactly, the news is at this point.

See More:

More in Science

Future Perfect
Human bodies aren’t ready to travel to Mars. Space medicine can help.Human bodies aren’t ready to travel to Mars. Space medicine can help.
Future Perfect

Protecting astronauts in space — and maybe even Mars — will help transform health on Earth.

By Shayna Korol
Podcasts
The importance of space toilets, explainedThe importance of space toilets, explained
Podcast
Podcasts

Houston, we have a plumbing problem.

By Peter Balonon-Rosen and Sean Rameswaram
Climate
How climate science is sneakily getting funded under TrumpHow climate science is sneakily getting funded under Trump
Climate

Scientists are keeping their climate work alive by any other name.

By Kate Yoder, Ayurella Horn-Muller and 1 more
Good Medicine
You can’t really “train” your brain. Here’s what you can do instead.You can’t really “train” your brain. Here’s what you can do instead.
Good Medicine

The best ways to protect your cognitive health might surprise you.

By Dylan Scott
Future Perfect
Humanity’s return to the moon is a deeply religious missionHumanity’s return to the moon is a deeply religious mission
Future Perfect

Space barons like Jeff Bezos and Elon Musk don’t seem religious. But their quest to colonize outer space is.

By Sigal Samuel
Health
Why the new GLP-1 pill is such a big dealWhy the new GLP-1 pill is such a big deal
Health

The FDA just approved Foundayo. Here’s what it can and can’t do.

By Dylan Scott